Evergreening: How Pharmaceutical Brands Delay Generic Drugs to Protect Profits
Evergreening lets pharmaceutical companies extend drug patents with minor changes, blocking cheaper generics and keeping prices high. Learn how it works, who it hurts, and what’s being done to stop it.